Bo Cai

712 total citations
34 papers, 437 citations indexed

About

Bo Cai is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Bo Cai has authored 34 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Hematology and 7 papers in Molecular Biology. Recurrent topics in Bo Cai's work include Hematopoietic Stem Cell Transplantation (9 papers), Acute Myeloid Leukemia Research (5 papers) and CAR-T cell therapy research (4 papers). Bo Cai is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), Acute Myeloid Leukemia Research (5 papers) and CAR-T cell therapy research (4 papers). Bo Cai collaborates with scholars based in China, United States and Australia. Bo Cai's co-authors include Jingcao Huang, Shuiliang Wang, Bolin Liu, Hui Lyu, Dongsong Li, Xingyu Zhao, Yu Han, Shuqiang Li, Hang Gao and Wei Feng and has published in prestigious journals such as Blood, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Bo Cai

32 papers receiving 435 citations

Peers

Bo Cai

ONCOL

RNMI

HEMAT

Yingjie Wang China

Yogesh Kumar Verma India

Deeksha Vishwamitra United States

Haizi Cheng United States

Anna Kulidjian United States

Antonina Coppola Italy

Yingjie Nie China

A. Papyan Germany

Rolf Habermann United States

Yingjie Wang China

Bo Cai

117 ×0.8

ONCOL

124 ×1.0

62 ×0.8

113 ×1.4

RNMI

29 ×0.4

HEMAT

Citations per year, relative to Bo Cai Bo Cai (= 1×) peers Yingjie Wang

Countries citing papers authored by Bo Cai

Since Specialization

Citations

This map shows the geographic impact of Bo Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Cai more than expected).

Fields of papers citing papers by Bo Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Cai. The network helps show where Bo Cai may publish in the future.

Co-authorship network of co-authors of Bo Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Cai. A scholar is included among the top collaborators of Bo Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Cai. Bo Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Hui, et al.. (2025). Durvalumab consolidation therapy in patients with stage III small cell lung cancer after concurrent chemoradiation: a China-based cost-effectiveness analysis. Frontiers in Oncology. 15. 1643022–1643022.

Zhang, Hao, et al.. (2025). Mapping the intersection of HIV and Alzheimer’s disease: a bibliometric analysis of emerging research trends. Frontiers in Neurology. 16. 1568022–1568022. 2 indexed citations

Yu, Hairong, Fei‐Hong Hu, Wen Tang, et al.. (2024). Body mass index and pressure injuries risk in hospitalized adult patients: A dose-response analysis. Journal of Tissue Viability. 33(3). 405–411.

Cai, Bo, et al.. (2024). Clinical features and risk factors of primary Sjögren’s syndrome complicated with severe pneumonia: a case–control study. Clinical Rheumatology. 43(5). 1665–1674. 1 indexed citations

Liu, Peng, Jie Zhang, Fei‐Hong Hu, et al.. (2024). Prevalence of anxiety, depression, sleeping problems, cognitive impairment, and suicidal ideation in people with autoimmune skin diseases. Journal of Psychiatric Research. 176. 311–324. 6 indexed citations

Han, Yu, et al.. (2024). 3D-printed Ti3C2/polycaprolactone composite scaffold with a DOPA-SDF1 surface modified for bone repair. Colloids and Surfaces B Biointerfaces. 248. 114470–114470. 2 indexed citations

Chen, Dezhi, Bo Cai, Yingying Zhu, et al.. (2024). Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer. Clinical Epigenetics. 16(1). 51–51. 11 indexed citations

Xu, Hong, Haizhen Chen, Yongsheng Chen, et al.. (2023). Survival of 48866 cancer patients: results from Nantong area, China. Frontiers in Oncology. 13. 1244545–1244545. 2 indexed citations

Hu, Kai‐Xun, Mei Guo, Jian‐Hui Qiao, et al.. (2023). Hematopoietic stem cell microtransplantation in patients aged over 70 with acute myeloid leukemia: a multicenter study.. PubMed. 13(4). 1509–1521. 2 indexed citations

10.

Hu, Kai‐Xun, Hui‐Sheng Ai, Mei Guo, et al.. (2020). Donor Selection in HLA-Mismatched Hematopoietic Stem Cell Microtransplantation for Acute Myeloid Leukemia. Stem Cells and Development. 29(10). 648–654. 6 indexed citations

11.

Deng, Lei, et al.. (2020). Effect of Dose Ratio on Mitoxantrone and Daunorubicin in Acute Myeloid Leukemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Clinical Lymphoma Myeloma & Leukemia. 21(1). e10–e20. 4 indexed citations

12.

Cai, Bo, Yao Wang, Zhiqiang Wu, et al.. (2020). Co-infusion of high-dose haploidentical donor cells and CD19-targeted CART cells achieves complete remission, successful donor engraftment and significant CART amplification in advanced ALL. Therapeutic Advances in Medical Oncology. 12. 3863542645–3863542645. 6 indexed citations

13.

Cai, Bo, Qi‐Yun Sun, Jian‐Hui Qiao, et al.. (2020). Comparison of microtransplantation, chemotherapy and allogeneic transplantation in post-remission therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia.. PubMed. 10(11). 3852–3866. 5 indexed citations

14.

Teng, Dengke, Lei Ding, Bo Cai, Qiang Luo, & Hui Wang. (2018). Interleukin-7 enhances anti-tumor activity of CD8+ T cells in patients with hepatocellular carcinoma. Cytokine. 118. 115–123. 24 indexed citations

15.

Cai, Bo, Mei Guo, & Hui‐Sheng Ai. (2018). Microtransplantation: clinical applications and mechanisms. Current Opinion in Hematology. 25(6). 417–424. 13 indexed citations

16.

Zhao, Xingyu, Yu Han, Jiawei Li, et al.. (2017). BMP-2 immobilized PLGA/hydroxyapatite fibrous scaffold via polydopamine stimulates osteoblast growth. Materials Science and Engineering C. 78. 658–666. 85 indexed citations

17.

Shen, Kaikai, Fangfang Lu, Jianling Xie, et al.. (2016). Cambogin exerts anti-proliferative and pro-apoptotic effects on breast adenocarcinoma through the induction of NADPH oxidase 1 and the alteration of mitochondrial morphology and dynamics. Oncotarget. 7(31). 50596–50611. 21 indexed citations

18.

Wang, Shuiliang, Jingcao Huang, Hui Lyu, et al.. (2013). Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer. Breast Cancer Research. 15(5). R101–R101. 42 indexed citations

19.

Huang, Jingcao, Shuiliang Wang, Hui Lyu, et al.. (2013). The anti-erbB3 antibody MM-121/SAR256212 in combination with trastuzumab exerts potent antitumor activity against trastuzumab-resistant breast cancer cells. Molecular Cancer. 12(1). 134–134. 54 indexed citations

20.

Yoshizawa, Katsuhiko, Julie F. Foley, Bo Cai, et al.. (2005). Mechanisms of Exocrine Pancreatic Toxicity Induced by Oral Treatment with 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Female Harlan Sprague-Dawley Rats. Toxicological Sciences. 85(1). 594–606. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact